Skip to main content
Hendrik Scholl, MD, Ophthalmology, Baltimore, MD

Hendrik Peter Scholl MD

Retinal Disease


Professor of Ophthalmology, Johns Hopkins University School of Medicine; Director, Retinal Degeneration Clinic, Dr. Frieda Derdeyn Bambas Professor of Ophthalmology, Director, Visual Neurophysiology Service, Co-director, Johns Hopkins Center for Stem Cells and Ophthalmic Regenerative Medicine (STORM)

Join to View Full Profile
  • 600 N Wolfe StBaltimore, MD 21287

  • Phone+1 410-955-5000

Dr. Scholl is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Rhode Island Hospital/Brown University Health
    Rhode Island Hospital/Brown University HealthResidency, Ophthalmology, 1996 - 1997
  • Rhode Island Hospital/Brown University Health
    Rhode Island Hospital/Brown University HealthPost-Doctoral Fellowship, Clinical Cardiac Electrophysiology, 1996 - 1997
  • Eberhard-Karls Univiversity
    Eberhard-Karls UniviversityMD, MA, 1989 - 1997
  • Eberhard-Karls Univiversity
    Eberhard-Karls UniviversityMD, MA, Medicine, Philosophy, 1989 - 1997
  • Eberhard-Karls Univiversity
    Eberhard-Karls UniviversityMD, MA, Medicine, Philosophy, Magna Cum Laude, 1989 - 1997
  • Eberhard-Karls University
    Eberhard-Karls UniversityMD, MA, Medicine, Philosophy, Magna Cum Laude, 1989 - 1997
  • Eberhard Karls University Faculty of Medicine
    Eberhard Karls University Faculty of MedicineClass of 1997, MD, MA

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2010 - 2017

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Earlier Role for Complement C3 Inhibitor in AMD?
    Earlier Role for Complement C3 Inhibitor in AMD?February 8th, 2022
  • Reversing Blindness: Award for Cone Optogenetics Gene Therapy
    Reversing Blindness: Award for Cone Optogenetics Gene TherapyApril 29th, 2021
  • Acucela Initiates Phase 2a Study of Emixustat Hydrochloride Addressing Patients with Stargardt Disease
    Acucela Initiates Phase 2a Study of Emixustat Hydrochloride Addressing Patients with Stargardt DiseaseJanuary 26th, 2017

Professional Memberships

Other Languages

  • German

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: